<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T01:26:39Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/126384" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/126384</identifier><datestamp>2025-11-25T00:57:09Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Novel valdecoxib derivatives by rutheniumIJII) promoted 1,3-dipolar cycloaddition of nitrile  oxides with alkynes– synthesis and COX-2  inhibition activity</dc:title>
   <dc:creator>Roscales García, Silvia</dc:creator>
   <dc:creator>Bechmann, Nicole</dc:creator>
   <dc:creator>Holger Weiss, Daniel</dc:creator>
   <dc:creator>Köckerling, Martin</dc:creator>
   <dc:creator>Pietzsch, Jens</dc:creator>
   <dc:creator>Kniess, Torsten</dc:creator>
   <dc:subject>547</dc:subject>
   <dc:subject>Química orgánica (Química)</dc:subject>
   <dc:subject>2306 Química Orgánica</dc:subject>
   <dc:description>Novel valdecoxib-based cyclooxygenase-2 inhibitors were synthesized in one step via 1,3-dipolar cycloaddition of nitrile oxides with a series of eleven aryl alkynes, six of them described for the first time. Application of RuIJII)-catalysis leads preferably to the formation of the 3,4-diaryl-substituted isoxazoles, while under thermal heating with base the 3,5-diaryl substitution pattern is favoured. The new the 3,4-diaryl-substituted isoxazoles possessing a small substituent (H and Me) displayed high COX-2 inhibition affinity (IC50 = 0.042-0.073 μM) and excellent selectivity (COX-2 SI > 2000). In contrast, the 3,5-diaryl substituted compounds displayed almost no COX activity. The introduction of a 4-fluorophenyl substituent resulted in retained high COX-2 affinity, making these compounds together with the feasible one step reaction promising candidates for the development of fluorine-18 labelled radiotracers.</dc:description>
   <dc:description>Fundación Ramón Areces</dc:description>
   <dc:description>European Commission-ERC</dc:description>
   <dc:description>Depto. de Química Orgánica</dc:description>
   <dc:description>Instituto Pluridisciplinar (IP)</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2025-11-24T11:58:31Z</dc:date>
   <dc:date>2025-11-24T11:58:31Z</dc:date>
   <dc:date>2018</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/126384</dc:identifier>
   <dc:identifier>XXXX-XXXX</dc:identifier>
   <dc:identifier>10.1039/c7md00575j</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Roscales S, Bechmann N, Weiss DH, Köckerling M, Pietzsch J, Kniess T. Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity. Med Chem Commun [Internet]. 2018 [citado 24 de noviembre de 2025];9(3):534-44. Disponible en: https://xlink.rsc.org/?DOI=C7MD00575J</dc:relation>
   <dc:rights>metadata only access</dc:rights>
   <dc:format>application/pdf</dc:format>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>